EVOLVE BIOLOGICS Trademark

Trademark Overview


On Friday, November 3, 2017, a trademark application was filed for EVOLVE BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the EVOLVE BIOLOGICS trademark a serial number of 87671420. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Therapure Biopharma Inc.. The EVOLVE BIOLOGICS trademark is filed in the Pharmaceutical Products, Construction & Repair Services, Treatment & Processing of Materials Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods

Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities

Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics

Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment

Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
evolve biologics

General Information


Serial Number87671420
Word MarkEVOLVE BIOLOGICS
Filing DateFriday, November 3, 2017
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6297746
Registration DateTuesday, March 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Disclaimer with Predetermined Text"BIOLOGICS"
Goods and ServicesBiologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
Goods and ServicesConstruction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
Goods and ServicesContract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
Goods and ServicesEducational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
Goods and ServicesDevelopment of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class037 - Building construction; repair; installation services.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code037
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEvolve Biologics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N 8G6
CA

Party NameTherapure Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Party NameTherapure Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Trademark Events


Event DateEvent Description
Wednesday, July 7, 2021REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, July 1, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 30, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, February 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 28, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, January 27, 2020WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Tuesday, January 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 10, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 1, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 19, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 19, 2019INQUIRY TO SUSPENSION E-MAILED
Tuesday, November 19, 2019SUSPENSION INQUIRY WRITTEN
Monday, November 18, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, October 30, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, May 18, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, May 18, 2019LETTER OF SUSPENSION E-MAILED
Saturday, May 18, 2019SUSPENSION LETTER WRITTEN
Thursday, May 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 9, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 14, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, November 14, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, November 14, 2018SUSPENSION INQUIRY WRITTEN
Wednesday, May 9, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 9, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, May 9, 2018SUSPENSION LETTER WRITTEN
Wednesday, May 9, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 2, 2018ASSIGNED TO LIE
Tuesday, April 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 16, 2018NON-FINAL ACTION E-MAILED
Friday, February 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 14, 2018ASSIGNED TO EXAMINER
Tuesday, November 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 7, 2017NEW APPLICATION ENTERED IN TRAM